In a 60‑kg woman requiring aggressive immunosuppression, which drugs should be started and what are their appropriate dosages and titration schedules?

Aggressive Immunosuppression Protocol for 60-kg Woman

For a 60-kg woman requiring aggressive immunosuppression, initiate a multi-drug regimen with high-dose methylprednisolone (60 mg IV daily for 3 days, then taper), plasmapheresis (daily or every other day for minimum 5 sessions), and IVIG (2 g/kg divided over 2 consecutive days on days 1-2 and 29-30), with consideration of additional agents based on clinical severity and response. 1

Initial Drug Selection and Dosing

First-Line Therapy (Start Immediately)

High-Dose Corticosteroids:

• Methylprednisolone 60 mg IV daily (1 mg/kg for 60-kg patient) for 3 consecutive days during initial evaluation
• After 3 days, transition to prednisone 60 mg PO daily (1 mg/kg)
• Maintain at 60 mg for 1 month minimum
• Do not reduce below 15 mg/day for first 3 months 2

Plasmapheresis:

• Daily or every other day sessions
• Minimum 5 sessions required
• Use 2× volume exchange 1

IVIG:

• 2 g/kg total dose (120 g for 60-kg patient)
• Divide into 2 doses over 2 consecutive days (60 g per day)
• Administer on days 1-2 and repeat on days 29-30
• Maximum single dose should not exceed 140 g 1

Premedications Required

Before each IVIG infusion:

• Diphenhydramine 60 mg (1 mg/kg)
• Acetaminophen 600-900 mg (10-15 mg/kg) 1

Escalation for Severe/Refractory Cases

T-Cell Depletion (If Hemodynamic Compromise)

Anti-thymocyte Globulin (Thymoglobulin):

• 1.5 mg/kg IV daily (90 mg for 60-kg patient)
• Continue for 3-7 days depending on severity
• First dose over minimum 6 hours; subsequent doses over 4 hours if via central line
• Use for 3 consecutive days with plasmapheresis in severe hemodynamic compromise 1

Steroid Protocol with ATG:

• Day 1: Methylprednisolone 60 mg IV (maximum 1 g)
• Day 2: Methylprednisolone 30 mg IV (maximum 500 mg)
• Day 3: Methylprednisolone 15 mg IV (maximum 250 mg)
• Then prednisone 60 mg PO for duration of thymoglobulin treatment 1

B-Cell Inhibition

Rituximab:

• 1 g IV on days 7 and 22 (for adults) 1
• Administer 60 minutes after bortezomib if using combination therapy
• Premedicate with diphenhydramine 60 mg and acetaminophen 600-900 mg 1

Cyclophosphamide (Alternative/Additional):

• 1.5 mg/kg/day (90 mg for 60-kg patient)
• Start IV for 2 days, then switch to oral at same dose
• Continue for 28 days total, then switch to mycophenolate 1

Proteasome Inhibition (Steroid-Refractory)

Bortezomib:

• Calculate body surface area (BSA) for 60-kg patient
• 1.3 mg/m² on days 1,4,8, and 11 1
• Administer methylprednisolone 30 minutes before each dose

Titration Schedule

Corticosteroid Taper (After Improvement to Grade ≤1)

Weeks 1-4: Maintain prednisone 60 mg daily

Month 2: Taper to 15 mg daily (do not go below this for first 3 months)

Months 3-4: Begin gradual taper

• Reduce by 5-10 mg every 1-2 weeks based on clinical response
• Target maintenance dose of 10 mg/day or less 2

Total taper duration: 4-6 weeks once improvement achieved 3

Monitoring During Titration

• Twice weekly initially for clinical response
• If no improvement in 2-3 days on initial dose, escalate to 2 mg/kg/day (120 mg for 60-kg patient) 3
• Re-dose IVIG monthly based on response 1

Maintenance Immunosuppression

After Remission Induction

Azathioprine (First Choice):

• 2 mg/kg/day (120 mg for 60-kg patient) 2
• Safer than long-term cyclophosphamide with equivalent efficacy at 18 months

Alternative: Mycophenolate Mofetil

• Switch from cyclophosphamide after 28-day course 1
• Requires therapeutic drug monitoring with AUC determinations 4

Alternative: Methotrexate

• 20-25 mg/week (oral or parenteral)
• Only if serum creatinine <1.5 mg/dL
• Start at 15 mg/week, escalate over 1-2 months 2

Critical Monitoring Parameters

Laboratory Surveillance

• Complete blood count: Twice weekly initially, then weekly
• Comprehensive metabolic panel: Weekly initially
• Drug levels (if using tacrolimus/cyclosporine): Twice weekly with goal 5-10 ng/mL 5
• Inflammatory markers (ESR, CRP): Weekly to assess response

Prophylaxis Requirements

Pneumocystis Prophylaxis (Mandatory):

• Trimethoprim/sulfamethoxazole 800/160 mg on alternate days OR 400/80 mg daily
• Start if >3 weeks of immunosuppression expected (>30 mg prednisone equivalent/day) 3, 2

GI Prophylaxis:

• Proton pump inhibitor for all patients on corticosteroids 3

Osteoporosis Prevention:

• Follow local guidelines for all patients on corticosteroids 2

Common Pitfalls to Avoid

1. Do not delay plasmapheresis while waiting for diagnostic confirmation in severe cases—start empirically 1

2. Do not reduce steroids too quickly—maintain >15 mg/day for first 3 months to prevent rebound 2

3. Do not administer plasmapheresis immediately after IVIG—it will remove the immunoglobulin 6

4. Do not use standard body weight calculations alone for drug dosing—significant inter-individual variability exists requiring therapeutic drug monitoring 4

5. Avoid nephrotoxic agents when possible—cyclophosphamide and calcineurin inhibitors require dose adjustment for renal function 7

6. Monitor for infections aggressively—immunosuppression increases risk of opportunistic infections requiring prophylaxis 2